BIODELIVERY SCIENCES INTERNATIONAL INC 4
4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed Aug 14, 2015
Insider Transaction Report
Form 4
STONE WILLIAM B
Director
Transactions
- Exercise/Conversion
Common Stock
2015-08-13+15,000→ 94,175 total - Exercise/Conversion
Common Stock
2015-08-13+15,000→ 109,175 total - Sale
Common Stock
2015-08-13$7.01/sh−11,500$80,615→ 97,675 total - Exercise/Conversion
Restricted Stock Units
2015-08-13−15,000→ 0 totalExercise: $0.00From: 2015-08-13Exp: 2015-08-13→ Common Stock (15,000 underlying) - Exercise/Conversion
Restricted Stock Units
2015-08-13−15,000→ 15,000 totalExercise: $0.00From: 2015-08-13→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on August 12, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended.
- [F2]The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on July 16, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest in the first open window following the Company's 2016 Annual Meeting of Stockholders.
- [F3]The shares of common stock were sold under a pre-planned 10b5-1 trading plan, and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
- [F4]On August 13, 2015, the Reporting Person sold an aggregate of 11,500 shares of the Issuer's Common Stock at a weighted average price of $7.01. The highest sale price for the Common Stock was $7.51 per share and the lowest sale price was $6.84 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.